Inovio to receive Orphan designation in EU for HPV-related diseases 

CHMP recommended EU approval of Roche’s Columvi in DLBCL

FDA raised question on efficacy of Merck/AZ’s Lynparza for prostate cancer

FDA granted Fast Track Designation for 177Lu-PNT2002 for the treatment of mCRPC

Ideaya’s Darovasertib + Crizotinib showed encouraging results in metastatic Uveal Melanoma